Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: a two-drug HIV treatment found equally effective as three drugs, experimental Ebola treatments show promise in lab study, and WHO upgrades list of essential diagnostic tests

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

GHTC/Matthew Robinson
One week of WHA, extensive debate, and two key R&D decisions

As happens every May, the World Health Organization’s (WHO) highest governing body, the World Health Assembly (WHA), met last week for its 69th annual meeting in Geneva, Switzerland. The agenda was the most packed in recent memory, consisting of more than 70 discussion items, many of which were controversial. Despite the lengthy agenda and difficult conversations, the WHA made two key decisions impacting global health research and development (R&D).

Read More
PATH
Research Roundup: Antimicrobial R&D, pandemic insurance, and Zika countermeasures

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Dorward / National Institute of Allergy and Infectious Diseases
Research Roundup: antimicrobial resistance, microbiomes, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO
WHO's doing WHA for the 69th time next week!

This coming week the “who’s who” of the global health community (as well as some much more modest global health advocates such as your humble author) will make the annual trek to Geneva, Switzerland, for the 69th World Health Assembly (WHA), where World Health Organization (WHO) member states will collectively decide WHO’s plans for the coming year.

Read More
PATH/Glenn Austin
Research Roundup: New insights into Zika virus, using silk to preserve blood samples, and a single dose oral cholera vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Jan Jacobs
Research Roundup: a rapid diagnostic for Ebola and fighting mosquito-borne diseases with soap and coconuts

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Doune Porter
Research Roundup: Yellow fever vaccine availability, protective antibodies against HIV, and the impact of past dengue infection on Zika fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Lesley Reed
Incentives and innovative financing mechanisms matter in addressing market failures

When existing market forces alone fall short in ensuring availability of and access to lifesaving health tools, a range of interventions are needed to alter the market and ultimately change the behavior of its actors.

GHTC
Read More
GHTC/Marissa Chmiola
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

GHTC
Read More
PATH/A. Golden
Research Roundup: an affordable hepatitis C regimen, rapid diagnostics for neglected diseases, and fighting Zika with tires and milk

GHTC member the Drugs for Neglected Diseases initiative will test an affordable hepatitis C regimen in Malaysia and Thailand, with a guarantee from generic drug manufacturer Pharco Pharmaceuticals that, if successful, the product will be priced at no more than US$294 for the entire regimen.

GHTC
Read More
Funding by crisis is no cure for global health threats

The Zika virus outbreak reinforces the need for US policymakers to stop funding by crisis and commit to sustainable, long-term investment in global health R&D.

GHTC
Read More
Research Roundup: legislation to expedite antibiotic R&D, a graduated approach to drug patents, and more

Scientists have described the first “teenage” broadly neutralizing antibody—an early stage version of the molecule, before developing the traits that make it effective against manifold HIV strains.

GHTC
Read More
President will redirect Ebola funds for Zika, but where is the money from and where will it go?

The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?

GHTC
Read More
Research Roundup: Mosquitos and mice in the fight against Zika

Is it feasible or wise to eradicate mosquitoes? Could genetically-modified mosquitoes help researcher tackle the Zika virus? Learn more in this week's Research Roundup.

GHTC
Read More
Research Roundup: Identifying people at-risk for TB, a device to aid IUD insertion, and vaccines against cancer

In this week's Research Roundup, we look at gene risk for tuberculosis, a new tool to help with inserting IUDs, and vaccines to prevent and treat cancer.

GHTC
Read More
Take 1.5 minutes for 1.5 million lives

In this guest post, Dara Erck, vice president of External Affairs at Aeras, a global nonprofit biotechnology organization, highlights a new video launched on World TB Day to raise awareness of the urgent need for new tools to combat tuberculosis (TB).

Aeras
Read More
Research Roundup: cash prizes for R&D, genetically modified mosquitoes, and drones for rapid diagnosis

US Senator Bernie Sanders (I-VT) released a plan last week as part of his Democratic presidential bid to incentivize research and development (R&D) for new HIV/AIDS medicines while ensuring they remain affordable.

GHTC
Read More
Research Roundup: antibiotic resistance in preemies, a low-cost TB test, and more

A new study out of the Washington University School of Medicine in St. Louis, Missouri, revealed a proliferation of antibiotic-resistant bacteria in the gastrointestinal tracts of premature infants.

GHTC
Read More
Innovative health tools put the power of protection in women’s hands

This International Women’s Day, GHTC is celebrating two novel, female-initiated health technologies that have the potential to give women and girls greater control over their sexual and reproductive health, empowering them to make informed decisions about whether and when to have children and to protect themselves and their families from HIV and other sexually transmitted infections (STIs).

GHTC
Read More
Better together? Five takeaways on the proposal for a WHO pooled fund

Last week, GHTC convened a panel of experts to dissect and discuss a proposal for pooled funding for global health research and development (R&D).

Read More